FDA panel backs approval of Roche drug in early breast cancer

By Toni Clarke (Reuters) - Roche Holding AG's drug Perjeta, currently approved to treat metastatic breast cancer, should also be approved to help shrink tumors prior to surgery, an advisory panel of the U.S. Food and Drug Administration said o...

Source: http://health.yahoo.net/news/s/nm/fda-panel-backs-approval-of-roche-drug-in-early-breast-cancer

site website view view site